Extended reports
Altered leucocyte trafficking and suppressed tumour necrosis
factor
release from peripheral blood monocytes after
intra-articular glucocorticoid treatment
a Department of
Pharmacology, University of Western Australia, Nedlands, Western
Australia, b Department of Rheumatology, Sir Charles Gairdner Hospital,
Nedlands, Western Australia, c Department of Clinical Pharmacology and Toxicology, Western
Australian Centre for Pathology and Medical Research, Nedlands, Western
Australia
Correspondence to: Dr D A Joyce, Department of Pharmacology, University of Western Australia, Nedlands, Western Australia, 6907.
Accepted for publication 17 September 1998
OBJECTIVES
A generalised transient improvement may
follow intra-articular administration of glucocorticoids to patients
with inflammatory arthropathy. This may represent a systemic
anti-inflammatory effect of glucocorticoid released from the joint,
mediated through processes such as altered leucocyte trafficking or
suppressed release of pro-inflammatory cytokines. Patients, who had
received intra-articular injections of glucocorticoids were therefore
studied for evidence of these two systemic effects.
METHODS
Patients with rheumatoid arthritis were
studied. Peripheral blood leucocyte counts, tumour necrosis factor
(TNF
) release by peripheral blood monocytes, blood cortisol
concentrations, and blood methylprednisolone concentration were
measured for 96 hours after intra-articular injection of
methylprednisolone acetate.
RESULTS
Measurable concentrations of
methylprednisolone were present in blood for up to 96 hours after
injection. Significant suppression of the
hypothalamic-pituitary-adrenal axis persisted throughout this time.
Altered monocyte and lymphocyte trafficking, as evidenced by peripheral
blood monocytopenia and lymphopenia, was apparent by four hours after
injection and resolved in concordance with the elimination of
methylprednisolone. Granulocytosis was observed at 24 and 48 hours.
Release of TNF
by endotoxin stimulated peripheral blood monocytes
was suppressed at four hours and thereafter. Suppression was maximal at
eight hours and was largely reversed by the glucocorticoid antagonist, mifepristone.
CONCLUSIONS
After intra-articular injection of
methylprednisolone, blood concentrations of glucocorticoid are
sufficient to suppress monocyte TNF
release for at least four days
and to transiently alter leucocyte trafficking. These effects help to
explain the transient systemic response to intra-articular
glucocorticoids. Suppression of TNF
is principally a direct
glucocorticoid effect, rather than a consequence of other
methylprednisolone induced changes to blood composition.
;
methylprednisolone;
human;
leucocyte trafficking
© 1998 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Flint, M. S., Tinkle, S. S.
(2001). C57BL/6 Mice Are Resistant to Acute Restraint Modulation of Cutaneous Hypersensitivity. Toxicol Sci
62: 250-256
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
